206274-13-7

Usage

Uses

Used in Pharmaceutical Industry:
1-BOC-4-CYCLOHEXYLAMINO-PIPERIDINE serves as a crucial intermediate in the synthesis of various pharmaceuticals. Its presence of a BOC protecting group and cyclohexylamine functionality allows for the development of complex molecular structures with specific biological activities, contributing to the creation of new drugs and therapeutic agents.
Used in Organic Synthesis:
In the field of organic synthesis, 1-BOC-4-CYCLOHEXYLAMINO-PIPERIDINE is employed as a versatile building block for the production of other organic compounds. Its unique structural features enable the formation of diverse chemical entities, which can be further modified or functionalized to achieve desired properties and applications.
Used in the Production of Bioactive Molecules:
1-BOC-4-CYCLOHEXYLAMINO-PIPERIDINE is also utilized in the synthesis of bioactive molecules, which possess specific biological activities and can interact with biological systems. Its structural components facilitate the development of molecules with potential applications in medicine, agriculture, and other industries that require bioactive compounds for various purposes.

Upstream product

• 79099-07-3 N-tert-butyloxycarbonylpiperidin-4-one 
• 108-91-8 cyclohexylamine 
• 108-94-1 cyclohexanone 
• 87120-72-7 1-(tert-butoxycarbonyl)-4-aminopiperidine 

Downstream Products

• 852486-61-4 N-cyclohexyl-piperidin-4-amine 
• 874986-12-6 tert-butyl 4-[cyclohexyl(2-ethoxy-2-oxoethyl)amino]piperidine-1-carboxylate 
• 874986-18-2 tert-butyl 4-[cyclohexyl(2-ethyl-butanoyl)amino]piperidine-1-carboxylate 
• 874986-06-8 tert-butyl 4-{cyclohexyl[(diethylamino)carbonyl]amino}-piperidine-1-carboxylate 
• 874986-34-2 tert-butyl 4-{cyclohexyl[(2,2-dimethylhydrazino)carbonyl]amino}piperidine-1-carboxylate 

Relevant academic research and scientific papers

Design, synthesis and antitubercular evaluation of benzothiazinones containing a piperidine moiety

We herein report the design and synthesis of benzothiazinones containing a piperidine moiety as new antitubercular agents based on the structure feature of IMB-ZR-1 discovered in our lab. Some of them were found to have good in vitro activity (MIC 1 μg/

NOVEL N-SULFAMOYL-PIPERIDINEAMIDES FOR THE PROPHYLAXIS OR TREATMENT OF OBESITY AND RELATED CONDITIONS

The present invention relates to novel N-sulfamoyl-piperidineamides of general formula (I) and their physiologically acceptable acid addition salts, to pharmaceutical compositions comprising them, processes for their preparation, and their use for the tre

N-Sulfamoyl-piperidineamides for the treatment or inhibition of obesity and related conditions

The present invention relates to novel N-sulfamoyl-piperidineamides of Formula I and their physiologically acceptable acid addition salts, to pharmaceutical compositions comprising them, processes for their preparation, and their use for the treatment of obesity and its concomitant and/or secondary diseases and related or other conditions.

AMINOPIPERIDINE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF

The present invention relates to compounds of formula (I) as defined herein that are melanocortin receptor agonists, to the preparation thereof and to the therapeutic use thereof in the treatment and in the prevention of obesity, diabetes and sexual dysfunctions that can affect both sexes, in the treatment of cardiovascular diseases, and also in anti-inflammatory uses or in the treatment of alcohol dependency.

HETEROARYL-UREAS AND THEIR USE AS GLUCOKINASE ACTIVATORS

This invention relates to compounds that are of formula (I) wherein A is heteroaryl and R1 and R2 are both cyclic residues, that are activators of glucokinase and thus may be useful for the management, treatment, control, or adjunct treatment of diseases,